Asche C - Search Results

1

3,4-Dihydro-1H-[1,3]oxazino[4,5-c]acridines as a new family of cytotoxic drugs.

Ouberai M, Asche C, Carrez D, Croisy A, Dumy P, Demeunynck M. Ouberai M, et al. Among authors: asche c. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4641-3. doi: 10.1016/j.bmcl.2006.05.101. Epub 2006 Jun 13. Bioorg Med Chem Lett. 2006. PMID: 16777412

2

Nitrobenzylcarbamate prodrugs of cytotoxic acridines for potential use with nitroreductase gene-directed enzyme prodrug therapy.

Asche C, Dumy P, Carrez D, Croisy A, Demeunynck M. Asche C, et al. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1990-4. doi: 10.1016/j.bmcl.2005.12.089. Epub 2006 Jan 26. Bioorg Med Chem Lett. 2006. PMID: 16442795

3

Antitumor carbazoles.

Asche C, Demeunynck M. Asche C, et al. Anticancer Agents Med Chem. 2007 Mar;7(2):247-67. doi: 10.2174/187152007780058678. Anticancer Agents Med Chem. 2007. PMID: 17348830 Review.

4

Synthesis, antitumour activity and structure-activity relationships of 5H-benzo[b]carbazoles.

Asche C, Frank W, Albert A, Kucklaender U. Asche C, et al. Bioorg Med Chem. 2005 Feb 1;13(3):819-37. doi: 10.1016/j.bmc.2004.10.038. Bioorg Med Chem. 2005. PMID: 15653349

5

Antitumour quinones.

Asche C. Asche C. Mini Rev Med Chem. 2005 May;5(5):449-67. doi: 10.2174/1389557053765556. Mini Rev Med Chem. 2005. PMID: 15892687 Review.

6

1,4,9,10-Anthradiquinone as precursor for antitumor compounds.

Schenck LW, Kuna K, Frank W, Albert A, Asche C, Kucklaender U. Schenck LW, et al. Among authors: asche c. Bioorg Med Chem. 2006 May 15;14(10):3599-614. doi: 10.1016/j.bmc.2006.01.026. Epub 2006 Feb 3. Bioorg Med Chem. 2006. PMID: 16458517

7

A new 4-nitrobenzyl carbonate prodrug of methyl 5-benzyl-2-hydroxy-11-methylene-6-oxo-5H-benzo[b]carbazole-1-carboxylate for potential use with nitroreductase-based gene-directed enzyme prodrug therapy (GDEPT).

Asche C, Kucklaender U. Asche C, et al. Pharmazie. 2006 Mar;61(3):244-5. doi: 10.1002/chin.200628210. Pharmazie. 2006. PMID: 16599269

8

The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report.

Zrubka Z, Champion A, Holtorf AP, Di Bidino R, Earla JR, Boltyenkov AT, Tabata-Kelly M, Asche C, Burrell A. Zrubka Z, et al. Among authors: asche c. Value Health. 2024 Apr;27(4):383-396. doi: 10.1016/j.jval.2024.01.009. Value Health. 2024. PMID: 38569772 Free article.

9

The Integration of Value Assessment and Social Network Methods for Breast Health Navigation Among African Americans.

Molina Y, Kao SY, Bergeron NQ, Strayhorn-Carter SM, Strahan DC, Asche C, Watson KS, Khanna AS, Hempstead B, Fitzpatrick V, Calhoun EA, McDougall J. Molina Y, et al. Among authors: asche c. Value Health. 2023 Oct;26(10):1494-1502. doi: 10.1016/j.jval.2023.06.001. Epub 2023 Jun 9. Value Health. 2023. PMID: 37301367

10

Associations in Cigarette Smoking and Health Conditions by Race/Ethnicity Among a Diverse Sample of Patients Receiving Treatment in a Federally Qualified Health Care Setting in Chicago.

Burke LA, Steffen AD, Kataria S, Watson KS, Winn RA, Oyaluade D, Williams B, Duangchan C, Asche C, Matthews AK. Burke LA, et al. Among authors: asche c. Health Equity. 2023 Feb 2;7(1):80-88. doi: 10.1089/heq.2022.0056. eCollection 2023. Health Equity. 2023. PMID: 36876237 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page